According to a newly published market research report by 24LifeSciences, global prophylactic hepatitis B virus vaccines market was valued at USD 2.7 billion in 2024 and is projected to reach USD 4.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period 2025-2031. Prophylactic hepatitis B virus vaccines are biological preparations containing...